3681 - 3690 of 9140 Results
Title
Year
-
OPENTitle: A technology evaluation of CVT-301 (Inbrija): an inhalable therapy for treatment of Parkinson’s diseaseJournal Name: Expert Opinion on Drug DeliveryPublisher: Informa UK LimitedVol: 18Issue #: 11Start Page: 1559End Page: 1569Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1080/17425247.2021.1960820Best OA location URL: https://www.tandfonline.com/doi/pdf/10.1080/17425247.2021.1960820?needAccess=trueCitation Count: 20
- Deep brain stimulation programming strategies: segmented leads, independent current sources, and future technology2021RESTRICTEDTitle: Deep brain stimulation programming strategies: segmented leads, independent current sources, and future technologyJournal Name: Expert Review of Medical DevicesPublisher: Informa UK LimitedVol: 18Issue #: 9Start Page: 875End Page: 891Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1080/17434440.2021.1962286Citation Count: 15
- Fast and robust supervised machine learning approach for classification and prediction of Parkinson’s disease onset2021RESTRICTEDTitle: Fast and robust supervised machine learning approach for classification and prediction of Parkinson’s disease onsetJournal Name: Computer Methods in Biomechanics and Biomedical Engineering: Imaging & VisualizationPublisher: Informa UK LimitedVol: 9Issue #: 6Start Page: 690End Page: 706Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1080/21681163.2021.1941262Citation Count: 13
- Olfactory dysfunction and striatal dopamine transporter binding in motor subtypes of Parkinson’s disease2022RESTRICTEDTitle: Olfactory dysfunction and striatal dopamine transporter binding in motor subtypes of Parkinson’s diseaseJournal Name: Neurological SciencesPublisher: Springer Science and Business Media LLCVol: 43Issue #: 8Start Page: 4745End Page: 4752Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1007/s10072-022-06110-yCitation Count: 8
-
OPENTitle: How to unblur the vasovagal evidence?Journal Name: Clinical Autonomic ResearchPublisher: Springer Science and Business Media LLCVol: 33Issue #: 1Start Page: 5End Page: 7Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1007/s10286-022-00915-9Best OA location URL: https://link.springer.com/content/pdf/10.1007/s10286-022-00915-9.pdfCitation Count: 1
- The path linking excessive daytime sleepiness and activity of daily living in Parkinson’s disease: the longitudinal mediation effect of autonomic dysfunction2022RESTRICTEDTitle: The path linking excessive daytime sleepiness and activity of daily living in Parkinson’s disease: the longitudinal mediation effect of autonomic dysfunctionJournal Name: Neurological SciencesPublisher: Springer Science and Business Media LLCVol: 43Issue #: 8Start Page: 4777End Page: 4784Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1007/s10072-022-06081-0Citation Count: 6
- Incidence of Parkinson’s disease in French women from the E3N cohort study over 27 years of follow-up2022RESTRICTEDTitle: Incidence of Parkinson’s disease in French women from the E3N cohort study over 27 years of follow-upJournal Name: European Journal of EpidemiologyPublisher: Springer Science and Business Media LLCVol: 37Issue #: 5Start Page: 513End Page: 523Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1007/s10654-022-00851-yCitation Count: 21
- Exogenous Tetranectin Alleviates Pre-formed-fibrils-induced Synucleinopathies in SH-SY5Y Cells by Activating the Plasminogen Activation System2022RESTRICTEDTitle: Exogenous Tetranectin Alleviates Pre-formed-fibrils-induced Synucleinopathies in SH-SY5Y Cells by Activating the Plasminogen Activation SystemJournal Name: Neurochemical ResearchPublisher: Springer Science and Business Media LLCVol: 47Issue #: 10Start Page: 3192End Page: 3201Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1007/s11064-022-03673-2Citation Count: 5
- Additive effects of mGluR2 positive allosteric modulation, mGluR2 orthosteric stimulation and 5-HT2AR antagonism on dyskinesia and psychosis-like behaviours in the MPTP-lesioned marmoset2021RESTRICTEDTitle: Additive effects of mGluR2 positive allosteric modulation, mGluR2 orthosteric stimulation and 5-HT2AR antagonism on dyskinesia and psychosis-like behaviours in the MPTP-lesioned marmosetJournal Name: Naunyn-Schmiedeberg's Archives of PharmacologyPublisher: Springer Science and Business Media LLCVol: 394Issue #: 12Start Page: 2381End Page: 2388Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1007/s00210-021-02162-7Citation Count: 3
- Further characterisation of psychosis-like behaviours induced by L-DOPA in the MPTP-lesioned marmoset2021RESTRICTEDTitle: Further characterisation of psychosis-like behaviours induced by L-DOPA in the MPTP-lesioned marmosetJournal Name: Naunyn-Schmiedeberg's Archives of PharmacologyPublisher: Springer Science and Business Media LLCVol: 394Issue #: 8Start Page: 1685End Page: 1692Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1007/s00210-021-02090-6Citation Count: 11